These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8150348)

  • 1. Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease.
    Swift GL; Srivastava ED; Stone R; Pullan RD; Newcombe RG; Rhodes J; Wilkinson S; Rhodes P; Roberts G; Lawrie BW
    Gut; 1994 Mar; 35(3):363-8. PubMed ID: 8150348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of rifampicin and ethambutol in Crohn's disease.
    Shaffer JL; Hughes S; Linaker BD; Baker RD; Turnberg LA
    Gut; 1984 Feb; 25(2):203-5. PubMed ID: 6363219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
    Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
    Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease.
    Goodgame RW; Kimball K; Akram S; Ike E; Ou CN; Sutton F; Graham D
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1861-6. PubMed ID: 11736715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
    Vermeire S; Schreiber S; Petryka R; Kuehbacher T; Hebuterne X; Roblin X; Klopocka M; Goldis A; Wisniewska-Jarosinska M; Baranovsky A; Sike R; Stoyanova K; Tasset C; Van der Aa A; Harrison P
    Lancet; 2017 Jan; 389(10066):266-275. PubMed ID: 27988142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled double blind study of azathioprine in the management of Crohn's disease.
    Candy S; Wright J; Gerber M; Adams G; Gerig M; Goodman R
    Gut; 1995 Nov; 37(5):674-8. PubMed ID: 8549944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study.
    Mahmud N; Kamm MA; Dupas JL; Jewell DP; O'Morain CA; Weir DG; Kelleher D
    Gut; 2001 Oct; 49(4):552-6. PubMed ID: 11559654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
    Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ
    Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease.
    Ewe K; Press AG; Singe CC; Stufler M; Ueberschaer B; Hommel G; Meyer zum Büschenfelde KH
    Gastroenterology; 1993 Aug; 105(2):367-72. PubMed ID: 8335191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
    Kalita J; Misra UK; Prasad S; Bhoi SK
    J Antimicrob Chemother; 2014 Aug; 69(8):2246-51. PubMed ID: 24752957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of corticosteroids in the treatment of tuberculous pleurisy.
    Galarza I; Cañete C; Granados A; Estopà R; Manresa F
    Thorax; 1995 Dec; 50(12):1305-7. PubMed ID: 8553306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.
    Yacyshyn BR; Chey WY; Goff J; Salzberg B; Baerg R; Buchman AL; Tami J; Yu R; Gibiansky E; Shanahan WR;
    Gut; 2002 Jul; 51(1):30-6. PubMed ID: 12077088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
    Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
    Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.